image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 6 days, don't miss out!

Telecom Plus

August 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TEP
  • Price:
  • 1812p
A nicely timed write-up with results slightly ahead of expectations. Pretax profit rose 21.5% to £116.9m (3% above forecast) for eps of 109.5p (FY’23: 98p).  The highlight was customer growth of 14% to just over 1 million, up from just 400,000 at the end of 2012! There was strong growth across the board with energy +10% to 1.68 million; broadband +6% to 375,000; mobile +18% to 466,000; and insurance +38% to 139,000. Mobile is expected to accelerate as a second mobile SIM will be included in the multi service bundle, but insurance is expected to be slightly lower than last year due to a temporary pause in sales to new customers whilst the products are reviewed by the FCA. Encouragingly, EBITDA-per-customer increased by £8 to ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author